Related Experiment Video
Updated: May 21, 2025

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts
Published on: January 8, 2022
Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma
Yue Pu1, Ziruoyu Wang2, Shishi Tao1,3
1Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Abstract:
Von Hippel-Lindau (VHL) is a tumor suppressor frequently mutated in renal cell carcinoma (RCC) and its loss has been considered as a target for therapeutic exploitation. In an effort to identify therapeutic vulnerabilities in VHL-deficient RCC, we found that SKPin C1, a SKP2 inhibitor, exhibited synthetic lethal effects on VHL-deficient RCC cells. SKPin C1 selectively disrupted spindle assembly in VHL-deficient RCC, leading to the induction of mitotic arrest and death. These effects were independent of its inhibitory action on SKP2. Our in-depth biochemical and molecular interaction studies reveal that SKPin C1 binds to tubulin and inhibits microtubule polymerization. Interestingly, anti-microtubule effect of SKPin C1 was much more pronounced in VHL-deficient RCC cells. Further mechanistic studies on the synthetic lethality reveal that VHL loss alters microtubule dynamics in cells, promoting microtubule growth speed while reducing stability. Treatment of VHL-deficient RCC cells with SKPin C1 or other microtubule destabilizers strongly suppressed microtubule growth and reduced the levels of GTP-tubulin and acetylated microtubules, resulting in selective vulnerability in VHL-deficient RCC. Taken together, our study suggests that microtubule dynamics is a therapeutic vulnerability in VHL-deficient RCC and provides a rationale for the combination treatment of VHL-deficient RCC with anti-microtubule agents and RCC targeted therapies.
Insights
Von Hippel-Lindau (VHL) deficiency creates a vulnerability in renal cell carcinoma (RCC) that can be targeted. SKPin C1, a microtubule-disrupting agent, selectively kills VHL-deficient RCC cells by altering microtubule dynamics.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Von Hippel-Lindau (VHL) is a tumor suppressor gene frequently mutated in renal cell carcinoma (RCC).
- Loss of VHL function is a potential therapeutic target in RCC.
- Identifying synthetic lethal interactions in VHL-deficient RCC is crucial for developing novel treatments.
Purpose of the Study:
- To identify therapeutic vulnerabilities in VHL-deficient RCC.
- To investigate the mechanism of action of SKPin C1 in VHL-deficient RCC cells.
- To explore the role of microtubule dynamics in VHL-deficient RCC.
Main Methods:
- Screening of VHL-deficient RCC cells with SKPin C1, a SKP2 inhibitor.
- Biochemical and molecular interaction studies to determine SKPin C1's binding targets.
- Analysis of microtubule dynamics, spindle assembly, and cell death induction.
- Assessment of GTP-tubulin and acetylated microtubule levels.
Main Results:
- SKPin C1 exhibited synthetic lethal effects on VHL-deficient RCC cells, independent of SKP2 inhibition.
- SKPin C1 selectively disrupted spindle assembly and induced mitotic arrest and death in VHL-deficient RCC.
- SKPin C1 binds to tubulin and inhibits microtubule polymerization, with a more pronounced effect in VHL-deficient cells.
- VHL loss alters microtubule dynamics, increasing growth speed and decreasing stability.
- SKPin C1 and other microtubule destabilizers suppressed microtubule growth and reduced GTP-tubulin and acetylated microtubules in VHL-deficient RCC.
Conclusions:
- Microtubule dynamics represent a therapeutic vulnerability in VHL-deficient RCC.
- SKPin C1 selectively targets VHL-deficient RCC by disrupting microtubule dynamics.
- Combination therapy of VHL-deficient RCC with anti-microtubule agents and targeted therapies is a promising strategy.
More Related Videos
Related Concept Videos
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Microtubule Instability
Microtubules
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
Microtubule Formation

